Entyvio IV infusion 300mg, manufactured by Takeda Pharmaceutical, contains vedolizumab (genetical recombination). This integrin blocker is used to treat moderately to severely active ulcerative colitis and Crohn’s disease in adults. It is supplied as 300mg x 1 bottle with YJ code 2399405F1020.
Entyvio IV infusion 300mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →